February 2022 Vol 8 No 1

This February 2022 issue covers many bases, from a heartbreaking story of a mother who swims to honor her 14-year-old daughter’s last wish before dying of bone cancer, to hospice and end-of-life care, to dealing with emotional stress, and more. Read More ›

Melanie Shepard was diagnosed with stage IIIB ovarian cancer during the pandemic; she shares her experience of receiving treatment and support during these uniquely stressful times. Read More ›

Diagnosed with breast cancer in 2021, Kim Kleinhardt made a mixed-media triptych collage to chronicle her journey, featuring her mother’s old dress patterns and medical records from her cancer care appointments. Read More ›

At her annual mammogram, Katrina Shaw made a decision that turned into a stroke of good fortune and prevented a delay of her diagnosis of invasive ductal carcinoma. Read More ›

Lucia Hernandez was forced to have a thyroidectomy, removal of the entire thyroid to treat her cancer, which caused her anxiety after having had an emergency gallbladder surgery that did not go well. Read More ›

HPV is a major cause of throat cancer and is rising in the United States. Learn about the symptoms of throat cancer, treatment options, and the benefits of a shorter course of treatment for certain patients. Read More ›

Sometimes we have to deal with the impossible. Vicki Bunke’s daughter, Grace, died from osteosarcoma, a rare bone cancer, a day before her 15th birthday. This is a heartbreaking story of how Vicki honored her daughter’s life. Read More ›

Imagination is a concept not often heard in the medical world, but using imagination and visualization may help patients with cancer cope with the psychological strain of cancer, as Petra Sprik and Kari Dawson show. Read More ›

Maimah Karmo was diagnosed with stage II triple-negative breast cancer at age 32. After her diagnosis, she was emboldened to fight against the injustices and inequalities black women face in navigating medical care. Read More ›

In January 2022, the FDA approved Kimmtrak (tebentafusp-tebn), a novel type of immunotherapy, for the treatment of adults with advanced or spreading uveal melanoma, a rare and aggressive type of melanoma that affects the eye. Kimmtrak is the first drug approved for this type of melanoma. Read More ›